Abstract
The antiphospholipid syndrome (APS, Hughes' syndrome), first described in 1983, is a prothrombotic disease in which neurological events feature prominently. Strokes, transient ischaemic attacks, and headaches (including migraine) are important complications. However, it is clear that other neurological symptoms, including diplopia, memory loss, ataxia, and "multiple sclerosis-like" features are common. A notable feature of Hughes' syndrome is the clinical response to anticoagulants; features such as headache and memory loss often improving dramatically with appropriate warfarin dosage. APS may well become recognised as an important (and potentially treatable) cause of neurological disease.
Full Text
The Full Text of this article is available as a PDF (45.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bertolaccini M. L., Atsumi T., Escudero Contreras A., Khamashta M. A., Hughes G. R. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. J Rheumatol. 2001 Dec;28(12):2637–2643. [PubMed] [Google Scholar]
- Cuadrado M. J., Khamashta M. A., Ballesteros A., Godfrey T., Simon M. J., Hughes G. R. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 2000 Jan;79(1):57–68. doi: 10.1097/00005792-200001000-00006. [DOI] [PubMed] [Google Scholar]
- Cuadrado M. J., Khamashta M. A., D'Cruz D., Hughes G. R. Migraine in Hughes syndrome--heparin as a therapeutic trial? QJM. 2001 Feb;94(2):114–115. doi: 10.1093/qjmed/94.2.114. [DOI] [PubMed] [Google Scholar]
- Cuadrado M. J., Khamashta M. A., Hughes G. R. Migraine and stroke in young women. QJM. 2000 May;93(5):317–318. doi: 10.1093/qjmed/93.5.317. [DOI] [PubMed] [Google Scholar]
- Cuadrado M. J., Khamashta M. A., Hughes G. R. Sticky blood and headache. Lupus. 2001;10(6):392–393. doi: 10.1191/096120301678646119. [DOI] [PubMed] [Google Scholar]
- Harris E. N., Gharavi A. E., Asherson R. A., Boey M. L., Hughes G. R. Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol. 1984 Jan-Mar;2(1):47–51. [PubMed] [Google Scholar]
- Hughes G. R. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) 1983 Oct 15;287(6399):1088–1089. doi: 10.1136/bmj.287.6399.1088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khamashta M. A., Cuadrado M. J., Mujic F., Taub N. A., Hunt B. J., Hughes G. R. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995 Apr 13;332(15):993–997. doi: 10.1056/NEJM199504133321504. [DOI] [PubMed] [Google Scholar]
- Mackworth-Young C. G., Hughes G. R. Epilepsy: an early symptom of systemic lupus erythematosus. J Neurol Neurosurg Psychiatry. 1985 Feb;48(2):185–185. doi: 10.1136/jnnp.48.2.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peltola J. T., Haapala A., Isojärvi J. I., Auvinen A., Palmio J., Latvala K., Kulmala P., Laine S., Vaarala O., Keränen T. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Am J Med. 2000 Dec 15;109(9):712–717. doi: 10.1016/s0002-9343(00)00617-3. [DOI] [PubMed] [Google Scholar]
- Shah N. M., Khamashta M. A., Atsumi T., Hughes G. R. Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus. 1998;7(1):3–6. doi: 10.1191/096120398678919624. [DOI] [PubMed] [Google Scholar]